Insufficient scRNA-seq data for expression of IL22RA2 at single-cell level.
Insufficient scRNA-seq data for expression of IL22RA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 57% | 31.61 | 261 / 459 | 17% | 0.88 | 191 / 1118 |
spleen | 70% | 23.18 | 169 / 241 | 0% | 0 | 0 / 0 |
skin | 67% | 15.51 | 1203 / 1809 | 4% | 0.10 | 17 / 472 |
tonsil | 0% | 0 | 0 / 0 | 60% | 2.27 | 27 / 45 |
lung | 21% | 2.31 | 122 / 578 | 35% | 1.29 | 409 / 1155 |
esophagus | 17% | 2.82 | 250 / 1445 | 21% | 1.21 | 39 / 183 |
intestine | 27% | 8.25 | 264 / 966 | 7% | 0.20 | 37 / 527 |
prostate | 28% | 3.43 | 69 / 245 | 2% | 0.10 | 11 / 502 |
heart | 28% | 2.10 | 245 / 861 | 0% | 0 | 0 / 0 |
uterus | 2% | 0.19 | 3 / 170 | 22% | 1.02 | 103 / 459 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.41 | 7 / 29 |
peripheral blood | 23% | 4.60 | 212 / 929 | 0% | 0 | 0 / 0 |
thymus | 6% | 0.73 | 38 / 653 | 14% | 0.37 | 84 / 605 |
pancreas | 0% | 0.01 | 1 / 328 | 19% | 0.42 | 34 / 178 |
bladder | 5% | 0.19 | 1 / 21 | 12% | 0.42 | 58 / 504 |
stomach | 5% | 0.48 | 19 / 359 | 9% | 0.20 | 27 / 286 |
ovary | 0% | 0 | 0 / 180 | 8% | 0.17 | 35 / 430 |
liver | 1% | 0.07 | 3 / 226 | 2% | 0.04 | 7 / 406 |
adipose | 2% | 0.15 | 30 / 1204 | 0% | 0 | 0 / 0 |
kidney | 1% | 0.07 | 1 / 89 | 1% | 0.02 | 8 / 901 |
blood vessel | 1% | 0.16 | 15 / 1335 | 0% | 0 | 0 / 0 |
brain | 0% | 0.03 | 9 / 2642 | 0% | 0 | 0 / 705 |
muscle | 0% | 0.01 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0042509 | Biological process | regulation of tyrosine phosphorylation of STAT protein |
GO_0140865 | Biological process | interleukin-22-mediated signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0042018 | Molecular function | interleukin-22 receptor activity |
GO_0042017 | Molecular function | interleukin-22 binding |
Gene name | IL22RA2 |
Protein name | Interleukin-22 receptor subunit alpha-2 (IL-22 receptor subunit alpha-2) (IL-22R-alpha-2) (IL-22RA2) (Cytokine receptor class-II member 10) (Cytokine receptor family 2 member 10) (CRF2-10) (Cytokine receptor family type 2, soluble 1) (CRF2-S1) (Interleukin-22-binding protein) (IL-22BP) (IL22BP) (ZcytoR16) |
Synonyms | UNQ5793/PRO19598/PRO19822 |
Description | FUNCTION: Isoform 2 is a receptor for IL22. Binds to IL22, prevents interaction with the functional IL-22R complex and blocks the activity of IL22 (in vitro). May play an important role as an IL22 antagonist in the regulation of inflammatory responses.; FUNCTION: Isoform 1 may play a role in establishing and maintaining successful pregnancy. |
Accessions | ENST00000339602.3 [Q969J5-3] ENST00000349184.9 [Q969J5-2] Q969J5 ENST00000296980.7 [Q969J5-1] |